Cathie Wood's prediction for a 20% gain in 2021 sours as Ark's flagship fund sees worst return since inception<blockquote>Cathie Wood对2021年增长20%的预测变得糟糕,因为Ark的旗舰基金出现了自成立以来最差的回报</blockquote>
Scottish biotech TC BioPharm lowers deal size by 40%, adds warrants ahead of $30 million US IPO<blockquote>苏格兰生物技术TC BioPharm将交易规模降低40%,并在3000万美元美国IPO前增加认股权证</blockquote>